Creative Enzymes, a professional enzymes provider located in New York, USA, always hammers at researches and trials in order to provide customers with various enzymes services as many as possible. Last week, the product manager of Creative Enzymes announced that the company has introduced several enzyme expression and purification services.
Chadds Fords, PA, June 5 2020: MOBILion Systems, Inc. is showcasing its first ion mobility separations product to the biopharma drug development and academic research markets, with data from its first beta users, during the American Society for Mass Spectrometry’s (ASMS) virtual conference.
- Exyte offers the new ExyCellR modular technology for fast-track construction of biologicals production facilities compliant with the current good manufacturing practice (cGMP).
- Univercells Technologies delivers the integrated NevoLine™ biomanufacturing platform, including scale-X™ bioreactors, for low footprint and economic large-scale production of viral products.
- The combined offer enables users to rapidly deploy prefabricated GMP vaccine manufacturing facilities in response to new disease outbreaks.
(Last updated: 12.05.2020)
Online marketplaces are websites with a “many-to-many” business logic. They can host multiple suppliers trading with multiple buyers via different e-commerce tools available as a part of a website functionality.
Why are online marketplaces great?
Online marketplaces can provide a substantial added value to its users. For example, buyers can quickly compare and select better offerings without the need to research multiple websites and surf online for price comparisons or product specifications. Additionally, marketplaces bring more transparency, trust, and standardization to the whole process of sourcing.
This Congress will explore the novel technologies and manufacturing strategies accelerating the efficient production of next-generation biologics.
With 30+ presentations over two days, this meeting focuses on key challenges within the field, evaluating innovative solutions such as continuous bioprocessing, SUTs, data integrity, PAT and the implementation of industry 4.0, all of which aim to increase the efficiency and yield of therapeutic production whilst maintaining high-quality standards. Once again, this meeting will also feature a track dedicated to the manufacturing of cell and gene therapies, exploring both the regulatory and manufacturing challenges of these complex products.